Expanded Access to Hemlibra for Moderate Hemophilia A
Canadian Blood Services (CBS) announced in May that the provinces and territories have agreed to expand access to emicizumab (Hemlibra) for people with moderate hemophilia A and a severe […]
Hemophilia A
Exploring the Lived Experience of Gene Therapy Webinar – October 3rd!
After Mike and Elizabeth presented on their experiences with Gene Therapy at our Annual General Meeting/Community Camp Weekend in May, a lot of really great conversation was sparked. We also […]
We are looking for some new Bingo Volunteers!
The TCOR region of Hemophilia Ontario is lucky to be one of the 55 charities that run bingo sessions at the Delta Downsview bingo hall at 1868 Wilson Avenue […]
Paid Interview Opportunity: Spaces Still Available
Hemophilia Ontario is conducting a gaps analysis to better understand the data from our 2020 needs assessment and also to support our 2023-2025 strategic plan. We are currently looking […]
Calling Hemophilia A & Hemophilia B Patients
MD Analytics Inc., an independent market research firm, is conducting a study to better understand the experiences of patients with Hemophilia. As part of the research, they are […]
Learn More About Hemophilia A and Inhibitors
Save the Date! June 30th at 5pm – more details to be posted soon! Join Hemophilia Ontario in collaboration with octapharma for a live webinar with Dr. Robert […]
Help Improve Care for Adults with Hemophilia A
Please give 15 minutes of your time to help us work to improve treatment regimes. We have 28 spots to fill, please consider being one of them! You […]
Join Us For a Live Webinar with Dr. Davide Matino!
Please join us in the upcoming webinar on Wednesday May 27th for Hemophilia A patients. To register, please visit: bit.ly/IndividualizeTherapy
